Across the globe, people from all walks of life will be making resolutions on New Year’s Eve, aiming, as they do every year, to have another stab at doing better in the areas they’ve lagged.
For financial advisors, the end of one year and the beginning of another is an excellent time to get their clients to commit to making at least one sound financial decision. Research has shown that New Year's Eve inspires positive behavioral tendencies in most people, said Katherine Milkman, the James G. Campbell Jr., assistant professor of operations and information management at the University of Pennsylvania’s Wharton School.
However, Milkman’s research has expanded the available body of evidence on the so-called New Year’s Effect by showing that human beings actually make positive resolutions at any number of different points in their lives.
“There are many points at which people start new cycles,” she said, “including the beginning of a new month, the start of a new week, their birthdays and a whole list of other landmark dates.”
Best Defensive Stocks To Own For 2015: Ishares Trust S & P Global * (IXJ)
iShares S&P Global Healthcare Sector Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Standard & Poor�� Global Healthcare Sector Index (the Index). The Index is a subset of the Standard & Poor�� Global 1200 Index, and measures the performance of companies that Standard & Poor�� deems to be a part of the healthcare sector. Component companies include healthcare providers, biotechnology companies, and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By MONEYMORNING.COM]
Consider the iShares S&P Global Healthcare Sect. (ETF) (NYSE: IXJ). While not a pure European play, it has one of the highest non-U.S. exposures in healthcare, most of which is European, and trades at a more reasonable P/E of 19. The fund is up 8.44% year to date and recently set a new all-time high, so it's definitely got momentum on its side.
Top 5 Healthcare Technology Companies To Own For 2014: NovaBay Pharmaceuticals Inc. (NBY)
NovaBay Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the development of various product candidates for the therapeutic needs of the anti-infective market. Its products include Aganocide compounds comprising NVC-422 that are synthetic molecules for the treatment of impetigo and adenoviral conjunctivitis, as well as for reducing the incidence of urinary catheter blockage and encrustation, and the associated urinary tract infections. The company is also involved in developing NeutroPhase, a solution for cleansing and debriding wounds. It has collaboration and license agreement with Galderma S.A. to develop and commercialize its Aganocide compounds, which covers acne, impetigo, and other dermatological conditions. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is based in Emeryville, California.
Advisors' Opinion:- [By CRWE]
NovaBay(r) Pharmaceuticals, Inc. (Amex:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide(r) compounds for the local non-systemic treatment and prevention of infections, reported that Tom Paulson, Chief Financial Officer, will present at the Rodman & Renshaw 14th Annual Healthcare Conference held September 9-11, 2012, in New York, NY.
Top 5 Healthcare Technology Companies To Own For 2014: Montalvo Spirits Inc (TQLA)
Montalvo Spirits Inc., incorporated on November 18, 2010, is a development-stage company. The Company develops, markets and distributes alcoholic beverages with initial offering being the Montalvo Tequila, primarily in the United States. The Company sells its products through a network of spirits distributors, who are licensed to distribute alcoholic beverages throughout the United States. The Company intends to focus on growing the market share of its initial products, the ultra-premium Montalvo line of tequilas, whose expressions include Plata, Reposado, Anejo and Extra-Anejo. The Company owns the Montalvo brand trademark and have exclusive worldwide master distribution rights to the brands.
The Company�� portfolio of alcoholic beverage brands includes additional spirits categories, as well as beer and wine, through additional importation and distribution contracts of existing brands. In addition, the Company may choose to develop new brands or acquire existing companies with their own brand portfolios. The Company�� subsidiary, Casa Montalvo, has an exclusive worldwide distribution agreement with Destilidora Huerta Real, S.A. de C.V., the producers of Montalvo Tequila. Montalvo, an ultra-premium tequila brand, is a handcrafted, formulated tequila produced from blue agave plants from the Lowlands of Jalisco, Mexico. Montalvo is available in four expressions: Plata, Reposado, Anejo and Extra-Anejo.
The Company competes with Diageo PLC, Pernod Ricard S.A., Bacardi Limited, Brown-Forman Corporation, Beam Inc., Remy Cointreau S.A. and Constellation Brands, Inc.
Advisors' Opinion:- [By CRWE]
Today, TQLA surged (+10.80%) up +0.042 at $.431 with 1,344,844 shares in play thus far (ref. google finance Delayed: 1:09PM EDT� September 24, 2013).
Montalvo Spirits, Inc. previously reported they have entered into a sales and marketing agreement with Prestige International Exports, LLC (“Prestige”). Prestige will represent the Montalvo Spirits portfolio brands in certain international markets, as well as provide sales and marketing support for Montalvo Tequila and Broken Heart Gin throughout the state of California, and will assist the Company in attempting to secure distribution in additional markets in the U.S.
Top 5 Healthcare Technology Companies To Own For 2014: FactSet Research Systems Inc. (FDS)
FactSet Research Systems Inc. provides financial and economic information to investment community worldwide. FactSet offers fundamental financial data on various companies, analytical applications, and client services to the portfolio managers, research and performance analysts, risk managers, marketing professionals, sell-side equity research professionals, investment bankers, and fixed income professionals. The company?s applications provide users access to company analysis, multicompany comparisons, industry analysis, company screening, portfolio analysis, predictive risk measurements, alphatesting, portfolio optimization and simulation, news and quotes, and tools to value and analyze fixed income securities and portfolios. FactSet combines commercial databases, including content regarding companies and securities from various markets into a single online platform of information and analytics. The company?s solutions for investment management professionals include analy zing market, sector, and fundamental series; offering applications for portfolio attribution, risk management, and quantitative analysis; building quant models and calculating risk; analyzing the nuances of the debt-driven market; viewing event transcripts and corporate event calendars; researching and analyzing companies, benchmarks, debt instruments, and economic series; integrating the client?s own data, such as portfolio holdings and research notes; and creating reports and presentations. FactSet?s solutions for investment banking professionals comprise creating models and presentations; tracking market performance and headlines; providing deal analytic and corporate governance servies; researching on public and private companies; auditing financials underlying SEC filings and annual reports; and providing access to reports via wireless handheld device. The company was founded in 1978 and is headquartered in Norwalk, Connecticut.
Advisors' Opinion:- [By Holly LaFon] et researches global market trends and develops analytical tools for investors. Of all of GuruFocus��5-star predictable companies, it has the highest return on assets at 27%. ROA has been increasing over the past several years. The average return on assets for the software industry for the trailing 12 months is 13.07%.
In 2011, the company�� total assets increased to $657 million from $645 the prior year. Its net income increased to $171 million from $150.
The All-in-One Screener is a fully customizable stock-searching tool just introduced by GuruFocus. Search for stocks according to your own set of requirements here.
- [By Gregory Wallace]
The upward momentum could continue. John Butters, senior earnings analyst with FactSet (FDS), wrote in a report that while analysts have dialed back earlier expectations, they "still expect a significant improvement in earnings growth in the fourth quarter of 2013 relative to recent quarters."
No comments:
Post a Comment